Where it comes from
- Made in
- Brain and other tissues, reported in 2022
- Sent out by
- Unknown; it is found in cerebrospinal fluid, where the level tracks with age
- Acts on
- Mitochondrial inner membrane
- Neurons
What it does
- Supports mitochondrial respiration and neuron survival, and raises oxygen consumption in cells 1
- A variant (D47N), carried by about a quarter of people of European ancestry, goes with roughly 30 percent higher odds of Alzheimer’s disease across four cohorts and with faster thinning of the parahippocampal and entorhinal cortex 1
- The first mitochondrial-encoded micropeptide identified directly by mass spectrometry, which is why it stands on firmer ground than the SHLPs 1
In medicine
Beyond the body’s own use
- Nothing is in trials. The question is whether SHMOOSE accounts for part of the mitochondrial contribution to Alzheimer’s disease, long suspected from variants whose mechanism was never found 1
- It is not taken outside medicine. Given to rats it shifted gene expression in the hypothalamus, which is a long way from a treatment 1
- The same approach, reading a mitochondrial variant as a change to a peptide rather than to an RNA, produced the SHLP2 finding in Parkinson’s disease, so this is a method as much as a molecule 2
Sources
This card describes what a medicine is for and what the evidence says; it recommends nothing. Talk to your clinician about anything you read here.